Premium Reports
340B 2020

340B 2020
Service Weighs Heavy in Purchasing Decisions (A Decision Insights Report)

Authored by: Jackson Tate and Sam Eaquinto January 22, 2020 | Read Time: 11  minutes

The 340B program is considered a critical savings opportunity for covered entities and their contracted pharmacies, and over the past couple of years, KLAS has noted an increase in provider organization purchase decisions in the third-party administrator space. Some organizations are putting out RFPs because their current contracts are ending, but many others are seeking out solutions to fill the functionality and service gaps of their current 340B vendor. Newer market entrants, such as PSG and RxStrategies, represent additional options to consider alongside the already-established market players. While organizations continue to look for new technology and functionality in potential vendor partners, factors like service, support, and relationships have proven to be key to long-term customer success. 

Healthcare Providers,
Want to see full details?

Not a Provider, contact us for pricing details.

 Download Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2020 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.